U.S. Capital Wealth Advisors’s Accendra Health ACH Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.8K	Buy	+10,000	New	+$23K	﹤0.01%	998

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

U.S. Capital Wealth Advisors's ACH Position: Q1 2026 in Review

U.S. Capital Wealth Advisors opened a new position in Accendra Health (ACH) in Q1 2026: 10,000 shares worth $22.8K. The stake represents ﹤0.01% of the portfolio and ranks #998 among its holdings.

142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

U.S. Capital Wealth Advisors held 10,000 shares of Accendra Health worth $22.8K as of Q1 2026.
Accendra Health was a new U.S. Capital Wealth Advisors position in Q1 2026.
Accendra Health made up ﹤0.01% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #998 holding.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.